Opportunity
SAM #CDER-2026-133241
FDA Solicitation for Ultrasonic Package for Buchi Mini Spray Dryer S-300
Buyer
Food and Drug Administration
Posted
July 08, 2026
Respond By
July 20, 2026
Identifier
CDER-2026-133241
NAICS
541330, 333249, 541715, 334516
The U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Testing and Research, is soliciting an Ultrasonic Package for the Buchi Mini Spray Dryer S-300 to support advanced pharmaceutical research. - Government Buyer: - U.S. Food and Drug Administration (FDA) - Center for Drug Evaluation and Research (CDER) - Office of Testing and Research - OEM Highlight: - Buchi (manufacturer of laboratory spray drying equipment) - Products/Services Requested: - Ultrasonic Package compatible with Buchi Mini Spray Dryer S-300 and B-290 - Must produce spray dried powders with particle sizes up to 60 microns, suitable for intranasal drug delivery - Includes one-year OEM warranty - Delivery, installation, and maintenance - Factory Acceptance Test and validation documentation - Training for six scientists - Unique/Notable Requirements: - Compatibility with both S-300 and B-290 models - Focus on particle size control for intranasal drug delivery research - Comprehensive support including installation, training, and validation
Description
The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) requires an Ultrasonic Package for Buchi Mini Spray Dryer S-300. Advanced pharmaceutical manufacturing is an innovative pharmaceutical manufacturing technology, which has the potential to enhance drug quality, improve the reliability and robustness of the manufacturing process and supply chain, and increase timely access to quality medicines for the American public. One of FDA’s research priorities is to explore advanced manufacturing techniques, including manufacturing of spray dried powder for intranasal drug delivery.
CDER requires an Ultrasonic Package for Buchi Mini Spray Dryer S-300 that can be installed on Buchi mini spray dryer S-300 and B-290. The ultrasonic nozzle should be capable of producing spray dried powders with ideal particle size for intranasal drug delivery (to produce particles up to sixty (60) microns).